HEADER CHAPERONE/CHAPERONE INHIBITOR 17-MAR-11 3R4N TITLE OPTIMIZATION OF POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE TITLE 2 PYRROLODINOPYRIMIDINE-CONTAINING INHIBITORS OF HEAT SHOCK PROTEIN 90. TITLE 3 IDENTIFICATION OF DEVELOPMENT CANDIDATE 2-AMINO-4-{4-CHLORO-2-[2-(4- TITLE 4 FLUORO-1H-PYRAZOL-1-YL)ETHOXY]-6-METHYLPHENYL}-N-(2,2- TITLE 5 DIFLUOROPROPYL)-5,7-DIHYDRO-6H-PYRROLO[3,4-D]PYRIMIDINE-6-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAT SHOCK PROTEIN HSP 90-ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 9-225; COMPND 5 SYNONYM: HEAT SHOCK 86 KDA, HSP 86, HSP86, RENAL CARCINOMA ANTIGEN COMPND 6 NY-REN-38; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSP90AA1, HSP90A, HSPC1, HSPCA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CHAPERONE, ATP BINDING, CHAPERONE-CHAPERONE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.S.GAJIWALA REVDAT 3 21-FEB-24 3R4N 1 REMARK SEQADV REVDAT 2 11-APR-12 3R4N 1 JRNL VERSN REVDAT 1 27-APR-11 3R4N 0 JRNL AUTH L.ZEHNDER,M.BENNETT,J.MENG,B.HUANG,S.NINKOVIC,F.WANG, JRNL AUTH 2 J.BRAGANZA,J.TATLOCK,T.JEWELL,J.Z.ZHOU,B.BURKE,J.WANG, JRNL AUTH 3 K.MAEGLEY,P.P.MEHTA,M.J.YIN,K.S.GAJIWALA,M.J.HICKEY, JRNL AUTH 4 S.YAMAZAKI,E.SMITH,P.KANG,A.SISTLA,E.DOVALSANTOS, JRNL AUTH 5 M.R.GEHRING,R.KANIA,M.WYTHES,P.P.KUNG JRNL TITL OPTIMIZATION OF POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE JRNL TITL 2 PYRROLODINOPYRIMIDINE-CONTAINING INHIBITORS OF HEAT SHOCK JRNL TITL 3 PROTEIN 90. IDENTIFICATION OF DEVELOPMENT CANDIDATE JRNL TITL 4 2-AMINO-4-{4-CHLORO-2-[2-(4-FLUORO-1H-PYRAZOL-1-YL) JRNL TITL 5 ETHOXY]-6-METHYLPHENYL}-N-(2,2-DIFLUOROPROPYL)-5, JRNL TITL 6 7-DIHYDRO-6H-PYRROLO[3,4-D]PYRIMIDINE-6-CARBOXAMIDE. JRNL REF J.MED.CHEM. V. 54 3368 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21438541 JRNL DOI 10.1021/JM200128M REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 684458.540 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 29258 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1447 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2320 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2320 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2842 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0040 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 30018 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8446 REMARK 3 BIN R VALUE (WORKING SET) : 0.1800 REMARK 3 BIN FREE R VALUE : 0.2250 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 253 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3520 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.29000 REMARK 3 B22 (A**2) : -1.15000 REMARK 3 B33 (A**2) : 1.44000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.08 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 0.900 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.560 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.370 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.050 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.160 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.260 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 44.46 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARA REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARA REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : FU3.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : 979.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3R4N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000064483. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 98 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29344 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 17.740 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : 0.05900 REMARK 200 FOR THE DATA SET : 24.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.22900 REMARK 200 R SYM FOR SHELL (I) : 0.22900 REMARK 200 FOR SHELL : 6.950 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % ETHYLENE GLYCOL, 0.1 M CITRATE REMARK 280 PHOSPHATE, 20 MM TCEP, PH 4.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.93750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.25300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.70200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.25300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.93750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.70200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 45.87500 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -39.70200 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 59.25300 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 8 REMARK 465 ASP A 9 REMARK 465 HIS A 231 REMARK 465 HIS A 232 REMARK 465 HIS A 233 REMARK 465 MET B 8 REMARK 465 HIS B 232 REMARK 465 HIS B 233 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 182 140.63 -171.96 REMARK 500 HIS A 228 -0.71 74.52 REMARK 500 ASP B 66 87.70 -152.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FU5 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FU5 B 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3R4M RELATED DB: PDB REMARK 900 RELATED ID: 3R4O RELATED DB: PDB REMARK 900 RELATED ID: 3R4P RELATED DB: PDB DBREF 3R4N A 9 225 UNP P07900 HS90A_HUMAN 9 225 DBREF 3R4N B 9 225 UNP P07900 HS90A_HUMAN 9 225 SEQADV 3R4N MET A 8 UNP P07900 EXPRESSION TAG SEQADV 3R4N LEU A 226 UNP P07900 EXPRESSION TAG SEQADV 3R4N GLU A 227 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS A 228 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS A 229 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS A 230 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS A 231 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS A 232 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS A 233 UNP P07900 EXPRESSION TAG SEQADV 3R4N MET B 8 UNP P07900 EXPRESSION TAG SEQADV 3R4N LEU B 226 UNP P07900 EXPRESSION TAG SEQADV 3R4N GLU B 227 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS B 228 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS B 229 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS B 230 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS B 231 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS B 232 UNP P07900 EXPRESSION TAG SEQADV 3R4N HIS B 233 UNP P07900 EXPRESSION TAG SEQRES 1 A 226 MET ASP GLN PRO MET GLU GLU GLU GLU VAL GLU THR PHE SEQRES 2 A 226 ALA PHE GLN ALA GLU ILE ALA GLN LEU MET SER LEU ILE SEQRES 3 A 226 ILE ASN THR PHE TYR SER ASN LYS GLU ILE PHE LEU ARG SEQRES 4 A 226 GLU LEU ILE SER ASN SER SER ASP ALA LEU ASP LYS ILE SEQRES 5 A 226 ARG TYR GLU SER LEU THR ASP PRO SER LYS LEU ASP SER SEQRES 6 A 226 GLY LYS GLU LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN SEQRES 7 A 226 ASP ARG THR LEU THR ILE VAL ASP THR GLY ILE GLY MET SEQRES 8 A 226 THR LYS ALA ASP LEU ILE ASN ASN LEU GLY THR ILE ALA SEQRES 9 A 226 LYS SER GLY THR LYS ALA PHE MET GLU ALA LEU GLN ALA SEQRES 10 A 226 GLY ALA ASP ILE SER MET ILE GLY GLN PHE GLY VAL GLY SEQRES 11 A 226 PHE TYR SER ALA TYR LEU VAL ALA GLU LYS VAL THR VAL SEQRES 12 A 226 ILE THR LYS HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SEQRES 13 A 226 SER SER ALA GLY GLY SER PHE THR VAL ARG THR ASP THR SEQRES 14 A 226 GLY GLU PRO MET GLY ARG GLY THR LYS VAL ILE LEU HIS SEQRES 15 A 226 LEU LYS GLU ASP GLN THR GLU TYR LEU GLU GLU ARG ARG SEQRES 16 A 226 ILE LYS GLU ILE VAL LYS LYS HIS SER GLN PHE ILE GLY SEQRES 17 A 226 TYR PRO ILE THR LEU PHE VAL GLU LYS GLU LEU GLU HIS SEQRES 18 A 226 HIS HIS HIS HIS HIS SEQRES 1 B 226 MET ASP GLN PRO MET GLU GLU GLU GLU VAL GLU THR PHE SEQRES 2 B 226 ALA PHE GLN ALA GLU ILE ALA GLN LEU MET SER LEU ILE SEQRES 3 B 226 ILE ASN THR PHE TYR SER ASN LYS GLU ILE PHE LEU ARG SEQRES 4 B 226 GLU LEU ILE SER ASN SER SER ASP ALA LEU ASP LYS ILE SEQRES 5 B 226 ARG TYR GLU SER LEU THR ASP PRO SER LYS LEU ASP SER SEQRES 6 B 226 GLY LYS GLU LEU HIS ILE ASN LEU ILE PRO ASN LYS GLN SEQRES 7 B 226 ASP ARG THR LEU THR ILE VAL ASP THR GLY ILE GLY MET SEQRES 8 B 226 THR LYS ALA ASP LEU ILE ASN ASN LEU GLY THR ILE ALA SEQRES 9 B 226 LYS SER GLY THR LYS ALA PHE MET GLU ALA LEU GLN ALA SEQRES 10 B 226 GLY ALA ASP ILE SER MET ILE GLY GLN PHE GLY VAL GLY SEQRES 11 B 226 PHE TYR SER ALA TYR LEU VAL ALA GLU LYS VAL THR VAL SEQRES 12 B 226 ILE THR LYS HIS ASN ASP ASP GLU GLN TYR ALA TRP GLU SEQRES 13 B 226 SER SER ALA GLY GLY SER PHE THR VAL ARG THR ASP THR SEQRES 14 B 226 GLY GLU PRO MET GLY ARG GLY THR LYS VAL ILE LEU HIS SEQRES 15 B 226 LEU LYS GLU ASP GLN THR GLU TYR LEU GLU GLU ARG ARG SEQRES 16 B 226 ILE LYS GLU ILE VAL LYS LYS HIS SER GLN PHE ILE GLY SEQRES 17 B 226 TYR PRO ILE THR LEU PHE VAL GLU LYS GLU LEU GLU HIS SEQRES 18 B 226 HIS HIS HIS HIS HIS HET FU5 A 901 23 HET FU5 B 901 23 HETNAM FU5 4-[2-CHLORO-6-(4,4,4-TRIFLUOROBUTOXY)PHENYL]-6- HETNAM 2 FU5 METHYLPYRIMIDIN-2-AMINE FORMUL 3 FU5 2(C15 H15 CL F3 N3 O) FORMUL 5 HOH *280(H2 O) HELIX 1 1 GLN A 23 THR A 36 1 14 HELIX 2 2 GLU A 42 ASP A 66 1 25 HELIX 3 3 PRO A 67 ASP A 71 5 5 HELIX 4 4 THR A 99 LEU A 107 1 9 HELIX 5 5 LYS A 112 ALA A 124 1 13 HELIX 6 6 ASP A 127 GLY A 135 5 9 HELIX 7 7 VAL A 136 LEU A 143 5 8 HELIX 8 8 GLU A 192 LEU A 198 5 7 HELIX 9 9 GLU A 199 SER A 211 1 13 HELIX 10 10 GLN B 23 THR B 36 1 14 HELIX 11 11 GLU B 42 ASP B 66 1 25 HELIX 12 12 PRO B 67 GLY B 73 5 7 HELIX 13 13 THR B 99 LEU B 107 1 9 HELIX 14 14 GLY B 114 GLY B 125 1 12 HELIX 15 15 ILE B 128 GLY B 135 5 8 HELIX 16 16 VAL B 136 LEU B 143 5 8 HELIX 17 17 GLU B 192 LEU B 198 5 7 HELIX 18 18 GLU B 199 SER B 211 1 13 SHEET 1 A 8 GLU A 18 ALA A 21 0 SHEET 2 A 8 SER A 169 THR A 174 -1 O PHE A 170 N PHE A 20 SHEET 3 A 8 GLN A 159 SER A 164 -1 N ALA A 161 O ARG A 173 SHEET 4 A 8 ALA A 145 LYS A 153 -1 N VAL A 150 O TRP A 162 SHEET 5 A 8 GLY A 183 LEU A 190 -1 O ILE A 187 N THR A 149 SHEET 6 A 8 THR A 88 ASP A 93 -1 N LEU A 89 O LEU A 188 SHEET 7 A 8 ILE A 78 ASN A 83 -1 N ASN A 79 O VAL A 92 SHEET 8 A 8 ILE A 218 LEU A 220 1 O THR A 219 N LEU A 80 SHEET 1 B 8 VAL B 17 ALA B 21 0 SHEET 2 B 8 SER B 169 THR B 174 -1 O PHE B 170 N PHE B 20 SHEET 3 B 8 GLN B 159 SER B 164 -1 N ALA B 161 O ARG B 173 SHEET 4 B 8 ALA B 145 LYS B 153 -1 N VAL B 150 O TRP B 162 SHEET 5 B 8 GLY B 183 LEU B 190 -1 O LYS B 185 N ILE B 151 SHEET 6 B 8 THR B 88 ASP B 93 -1 N LEU B 89 O LEU B 188 SHEET 7 B 8 ILE B 78 ASN B 83 -1 N ASN B 83 O THR B 88 SHEET 8 B 8 ILE B 218 LEU B 220 1 O THR B 219 N LEU B 80 SITE 1 AC1 14 HOH A 5 HOH A 6 ASN A 51 SER A 52 SITE 2 AC1 14 ASP A 54 ALA A 55 LYS A 58 ASP A 93 SITE 3 AC1 14 GLY A 97 MET A 98 LEU A 107 PHE A 138 SITE 4 AC1 14 THR A 184 HOH A 250 SITE 1 AC2 14 HOH B 1 ASN B 51 SER B 52 ASP B 54 SITE 2 AC2 14 ALA B 55 LYS B 58 ASP B 93 GLY B 97 SITE 3 AC2 14 MET B 98 LEU B 107 PHE B 138 THR B 184 SITE 4 AC2 14 HOH B 238 HOH B 245 CRYST1 45.875 79.404 118.506 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021798 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012594 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008438 0.00000